INVX vs TECH · P/E 8.0, rev $660.8M vs P/E 65, rev $1.22B
Innovex International, Inc (INVX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Innovex International, Inc (INVX) is a oil & gas equipment & services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported INVX revenue for 2024-12-31 was $660.8M. Net income was $140.3M. Revenue was up 55.8% from 2023-12-31 to 2024-12-31. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
INVX currently screens at market cap $1.10B and trailing P/E 8.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the INVX and TECH stock pages for the full models.
Not investment advice.